skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling

Oncotarget, 2022, Vol.13 (1), p.695-706

Copyright: © 2022 Pu et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28234 ;PMID: 35601606

Full text available

Citations Cited by
  • Title:
    CancerOmicsNet: a multi-omics network-based approach to anti-cancer drug profiling
  • Author: Pu, Limeng ; Singha, Manali ; Ramanujam, Jagannathan ; Brylinski, Michal
  • Subjects: Research Paper
  • Is Part Of: Oncotarget, 2022, Vol.13 (1), p.695-706
  • Description: Development of novel anti-cancer treatments requires not only a comprehensive knowledge of cancer processes and drug mechanisms of action, but also the ability to accurately predict the response of various cancer cell lines to therapeutics. Numerous computational methods have been developed to address this issue, including algorithms employing supervised machine learning. Nonetheless, high prediction accuracies reported for many of these techniques may result from a significant overlap among training, validation, and testing sets, making existing predictors inapplicable to new data. To address these issues, we developed CancerOmicsNet, a graph neural network with sophisticated attention propagation mechanisms to predict the therapeutic effects of kinase inhibitors across various tumors. Emphasizing on the system-level complexity of cancer, CancerOmicsNet integrates multiple heterogeneous data, such as biological networks, genomics, inhibitor profiling, and gene-disease associations, into a unified graph structure. The performance of CancerOmicsNet, properly cross-validated at the tissue level, is 0.83 in terms of the area under the receiver operating characteristics, which is notably higher than those measured for other approaches. CancerOmicsNet generalizes well to unseen data, i.e., it can predict therapeutic effects across a variety of cancer cell lines and inhibitors. CancerOmicsNet is freely available to the academic community at https://github.com/pulimeng/CancerOmicsNet.
  • Publisher: United States: Impact Journals LLC
  • Language: English
  • Identifier: ISSN: 1949-2553
    EISSN: 1949-2553
    DOI: 10.18632/oncotarget.28234
    PMID: 35601606
  • Source: Geneva Foundation Free Medical Journals at publisher websites
    PubMed Central
    Alma/SFX Local Collection
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait